Transient activation of estrogen receptors (ER) in the developing brain during a limited perinatal "window of time" is recognized as a key mechanism of defeminization of neural control of reproductive function and sexual behavior. Two major ER isoforms, α and β, are present in neural circuits that govern ovarian cycle and sexual behavior. Using highly selective ER agonists, this study provides the first evidence for distinct contribution of individual ER isoforms to the process of estrogen dependent defeminization. Neonatal activation of the ERα in female rats resulted in abrogation of cyclic ovarian activity and female sexual behavior in adulthood. These effects are associated with male-like alterations in the morphology of the anteroventral periventricular (AVPV) and sexually dimorphic nucleus of the preoptic area (SDN-POA), as well as refractoriness to estrogen-mediated induction of sexual receptivity. Exposure to an ERβ-selective agonist induced persistent estrus and had a strong defeminizing effect on the hypothalamic gonadotropin "surge generator" AVPV. However, neonatal ERβ activation failed to alter female sexual behavior, responsiveness to estrogens and morphometric features of the behaviorally relevant SDN-POA. Thus, although co-present in several brain regions involved in the control of female reproductive function, ER isoforms convey different, and probably not synergistic, chemical signals in the course of neonatal sex-specific brain organization.
defeminization (7) . In addition, several morphological correlates of brain defeminization have been described in the rat. These are best exemplified by hormone-induced alterations in cellular density and nuclear volume of brain structures with known sexual dimorphism, such as the sexually dimorphic nucleus of the preoptic area (SDN-POA) (8) and anteroventral periventricular nucleus (AVPV) (9) . Numerous earlier studies have provided evidence for the involvement of these brain areas in the regulation of sexual behavior (10) and cyclic gonadotropin secretion (11) , respectively.
In the mammalian brain, two isoforms of ER, α (ERα) and β (ERβ), were shown to have distinct, region-specific distribution (12, 13) . These mapping studies led to the view that ER isoforms might play differential roles in the mediation of neurotropic effects of estrogens (2) . However, the individual contribution of ER isoforms to perinatal sex-specific brain organization, an ER-mediated process with life-long consequences for brain morphology, reproductive function and behavior, has not been elucidated. The synthesis of isoform-selective ER agonists (14) has now provided powerful tools for the pharmacological dissection of the contribution of individual ER isoforms to estrogen-dependent organization of reproduction-relevant neuroendocrine circuits and behavior. In the present study, we examined the long-term consequences of transient early postnatal exposure of female rats to the ERα-and ERβ-selective agonists ZK 281471 and ZK 281738 on ovarian cycle, female sexual receptivity, and morphometric signs of sexual dimorphism in relevant neuronal populations.
MATERIALS AND METHODS

Compounds
The isoform-selective ER agonists ZK 281471 and ZK 281738 were generously provided by Schering AG (Berlin, Germany); the non-selective cognate ligand of both ERα and ERβ, 17β-estradiol (Sigma, St. Louis, MO) was used as reference. As reported elsewhere (14) , the compound ZK 281471 (3,17β-dihydroxy-19-nor-17α-pregna-1,3,5(10)-triene-21,16α-lactone) displayed a 70-fold preference for the human ERα in binding assays; half-maximal transcriptional activation of an estrogen-dependent reporter revealed a 308-fold dissociation in favor of the ERα. The compound's potency in reporter transactivation was comparable with that of 17β-estradiol. The ERβ-selective agonist ZK 281738 (8β-vinyl-estra-1,3,5(10)-triene-3,17β-diol) has shown 180-and 190-fold preference for the human ERβ in radioligand binding and reporter transactivation assays, respectively. The compound's potency corresponded to 38% of that of 17β-estradiol. These potency calculations were taken into consideration for the selection of treatment doses in vivo.
Animal protocol
Newborn female Wistar rats (Charles River, Sulzfeld, Germany) from timed pregnancies were assigned to litters of 7-8 and received s.c. injections with ZK 281471, ZK 281738 or 17β-estradiol at daily doses of 5, 12.5, and 5 µg/rat, respectively, on every second day for the first 12 postnatal days. Controls were treated with vehicle (peanut oil) according to the same schedule. Rats were weaned at the age of 21 days and housed in groups of 5 under controlled environmental conditions (temperature 24°C, air humidity 65%, lights on between 6 PM and 6 AM) and free access to standard diet (Altromin, Lage, Germany) and tap water. Male littermates were used as reference for morphometric studies.
Evaluation of cyclic ovarian function was based on changes in vaginal cytology for 12 consecutive days from the 60th day of life on. Sequences of estrous cytology interrupted by at least two days of met-or diestrus were recorded as a single cycle.
Female sexual behavior was evaluated under two experimental conditions: in gonad-intact random-cycling animals, and upon gonadectomy under s.c. priming with estradiol benzoate at a daily dose of 5 µg/rat. These experiments were done between 90 and 120 days of age, using sexually experienced stud males; the investigator was unaware of the neonatal treatment. Under each condition, behavioral patterns were recorded and lordosis quotients (15) computed in at least three sessions (exposure to a male for 5 min) on different days during the dark phase of the diurnal cycle. In random-cycling animals, lordosis quotients were calculated only for those rats whose vaginal smears displayed a receptive phase (i.e., estrus) on the day of testing (i.e., behavioral records in di-or metestrous females were not taken into consideration).
All procedures were in compliance with national and NIH guidelines on animal welfare and the study protocols were previously approved by the corresponding authorities.
Morphometry of sexually dimorphic neuronal populations
Upon sacrifice by decapitation, brains were snap-frozen in pre-chilled isopentane and stored at -80°C until processing. Serial coronal cryosections of 10-µm thickness were collected from the area delineated between bregma 0.00 and -0.50 (16) , thus, containing the entire rostrocaudal extension of the anteroventral periventricular (AVPV) and the sexually dimorphic (SDN-POA) nuclei of the preoptic area. After cresyl violet staining, sections containing the nuclei of interest were selected for determination of the cellular density of the AVPV and the volume of the SDN-POA.
In the AVPV, measurements were performed in three consecutive sections encompassing the area of maximal lateral extension of the nucleus (i.e., between bregma -0.15 and -0.25). The borders of the AVPV were defined by an unbiased investigator. Cells displaying clear signs of glial morphology were excluded from counting. In each section, neuronal densities were bilaterally determined in 4 (2 on each side) separate fields of pre-set size and location within the structure using the image analysis system Zeiss Axioskop and software KS400 (Zeiss, Oberkochen, Germany). Thus, for each individual, a total of 12 measurements were performed; from these data, expressed as number of neurons per area unit, individual mean values were calculated and, subsequently, used for statistic comparisons.
Determinations of the volume of SDN-POA were based on bilateral measurements of the nuclear area in three sections from each individual involving the rostral, medial and caudal extension of the structure (selection from sections located between bregma -0.40 and -0.50). Using the threshold discrimination tool of the Image Pro Plus 4.5 software (Media Cybernetics, Silver Spring, MD) SDN-POA was virtually highlighted in each section by an unbiased investigator, and delineated area was measured in µm 2 . The nuclear volume of the SDN-POA was then calculated according to Cavalieri's principle (17) . The length of the rostrocaudal axis was determined for each individual on the basis of serial sections throughout the structure.
Data processing
Cyclic ovarian activity in each experimental group was assessed by the number of cycles and by the number of days with estrous vaginal cytology within the observation period of 12 days. Female sexual behavior was quantified by average lordosis quotients recorded in three independent sessions. Statistic comparisons were performed using non-parametric ANOVA, followed by the Dunn test, where appropriate.
Morphometric data are expressed as cellular densities per area unit (AVPV) and nuclear volume in mm 3 (SDN-POA). Statistic evaluation was done by one-way ANOVA and subsequent Dunnett test. Level of significance was preset at P < 0.05.
RESULTS
Administration of the selective ER agonists ZK 281471 (ERα−agonist) and ZK 281738 (ERβ−agonist) to female rats during the first two weeks of postnatal life led to significant suppression of ovarian cycle frequency in adulthood, in association with extended duration of the estrus phase (Fig. 1 ).
Morphometric comparison of cellular densities within the sexually dimorphic AVPV, a brain region considered as a surge generator of cyclic gonadotropin secretion, demonstrated that selective activation of either ER isoform results in morphological changes (i.e., decreased cellular densities), which resemble those seen in genetically male individuals ( Fig. 2a and 2b) . However, between-group comparisons revealed that the "defeminizing" effect of the ERβ-selective agonist on this parameter was significantly stronger than that of the ERα-selective compound.
Neonatal treatment with ERα-, but not ERβ-selective, agonists resulted in abolition of femalespecific sexual behavior in adulthood. Interestingly, rats that had received neonatal treatment with either estradiol or the ERα-selective agonist ZK 281471 were also refractory to induction of lordosis behavior by estradiol priming in adulthood (Fig. 3) ; this finding suggests that neonatal activation of the ERα results in decreased responsiveness to estrogens. Examination of treatment-related morphological alterations in the SDN-POA revealed that exposure to ERα-agonists was associated with clear male-like increases in the volume of this nucleus, whereas treatment with the ERβ-selective ligand ZK 281738 failed to produce signs of morphological defeminization in the SDN-POA (Fig. 4a and 4b ).
DISCUSSION
Abrogation of female sexual behavior and cyclic ovarian activity, in association with morphometric alterations in sexually dimorphic neuronal populations, are well-established correlates of mal-differentiation of the female rat brain as a result of perinatal exposure to inappropriate testosterone or estrogen concentrations (2, 3, 5, 6, 18) . Synthetic estrogens and phytoestrogens as components of diet have been presumed to interfere with sex-specific brain organization in a sex hormone-like mode (19) . Early studies with the ERβ-preferring phytoestrogen genistein have shown influence suggestive of defeminization (20) ; however, the high doses of genistein used in those experiments cannot exclude effects resulting from residual ERα activation. The discovery of individual ER isoforms and evidence for their differential distribution throughout the mammalian brain poses the question of whether the two major ER subtypes contribute jointly or separately to the process of estrogen-dependent brain defeminization. This question gains importance also in conjunction with the increasing clinical use of selective ER modulators (SERM), which, reportedly, may favor interaction with a defined ER isoform (21).
Because both ER isoforms are present in the neuronal populations examined (12, 13) and, under natural conditions, sex-specific brain differentiation occurs under the influence of the nonselective ER agonist 17β-estradiol, this study demonstrates for the first time evidence for distinct contribution of individual ER subtypes.
Our findings suggest that the two major ER-subtypes have different roles in the process of neonatal brain differentiation and its functional correlates. Although we observed after application of the ERα-agonist ZK 281471 or the mixed agonist 17β-estradiol all classic consequences of neonatal estrogen exposure, selective ERβ-activation seems to act in a rather restricted fashion.
According to the present results, both ER subtypes can account for defeminization of circuits involved in the control of gonadal activity, and morphological changes in the sexually dimorphic AVPV suggest that this neuronal population may be a major common target for ER-mediated signaling in this process. Interestingly, we observed gradual differences in the strength of defeminizing action of isoform-selective agonists on neuronal densities in the AVPV. The order of potency ERβ > estradiol > ERα suggests that ERβ activation may play a crucial role; the question of whether concomitant activation of ERα may result in attenuation of ERβ effects deserves further attention. On the other hand, activation of ERα seems to be a critical prerequisite for abolition of female sexual behavior following early postnatal estrogen exposure. Significant changes in the SDN-POA, a neuronal population with significant involvement in the control of sexual behavior, as well as loss of sexual receptivity in adulthood, were documented in animals receiving estradiol and the ERα-specific, but not the ERβ-selective, agonist. Although the correlation between morphometric and behavioral changes is supportive of a specific role of ERα, it is difficult to explain why activation of ERβ remains ineffective, despite substantial presence of this ER isoform in the SDN-POA (12, 13) . At present, we speculate that the two ER isoforms may not share their cellular and/or neurochemical targets in this brain region, thus differentially influencing its morphology. Findings deduced from animals with targeted disruption of individual ER-isoforms (22) are, to certain extent, confounding, due to very early onset and life-long presence of aberrant ER signaling in the CNS. Further, it is prudent to consider that hormonal effects on sexual behavior also can be mediated by estrogen-sensitive neural substrates other than SDN-POA. Elicitation of lordosis behavior is based on an intricate sensorymotor neural circuit (23), and ERα is the dominant isoform in several of its components, such as the ventromedial nucleus and mesencephalic central gray (12, 13) . Thus, relative paucity of ERβ in these regions of integrative role in the lordosis reflex may ultimately account for the poor efficacy of ERβ-selective agonists. Because these brain areas display modest (if any) morphological sexual dichotomy (24) they have not been closely examined in the present study.
The refractoriness of female rats treated with the ERα-selective agonist to behavioral induction by estrogen priming suggests that neonatal activation of ERα may result in irreversible obliteration of female-specific estrogen responsiveness, probably through homologous downregulation of ER signaling. This assumption is supported by reports of decreasing abundance of ER in the male preoptic area during brain development as a result of perinatal exposure to testosterone-derived estrogens (25); however, the capacity of isoform-selective ER agonists to produce homo-and heterologous receptor down-regulation in relevant brain areas remains to be examined.
Taken together, these results suggest that neonatal activation of either ER isoform in female rats is sufficient for defeminization of the LH surge generator and suppression of cyclic ovarian activity in adulthood, whereas estrogen-induced abrogation of female sexual receptivity and refractoriness to estradiol-mediated behavioral induction can be largely ascribed to ERα occupation during early ontogeny. Further, these data provide the first evidence that the two ER isoforms are functional during early brain development, and have distinct contribution to different aspects of sex hormone-dependent brain differentiation. 
